ArticleJournal of molecular histology2025
Comparative analysis with stem cell therapy in rats with pharyngocutaneous fistula formation.
Article in Journal of molecular histology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Laryngocutaneous fistula is one of the most important complications encountered after larynx surgery. Stem cell therapy is a promising treatment approach for the future, both without the need for surgical methods and by assisting surgical methods to close the fistula. 30 female Downey Sprague rats were divided into 5 separate groups and pharyngocutaneous fistula was created. Stem cells were administered subcutaneously to Group 1(SC-SC) after the creation of PCF, and via the tail vein to Group 2 (V-SC). The 3rd group (C) was made as a control group and while fistula formation and subsequent closure characteristics in the neck were monitored without any treatment, the rats in the 4th group (V-M/SH) were given tail vein medium/sham and the 5th group (SC-M/SH) was given as subcutaneous medium/sham group. PCF closure was significantly higher in the group given SC compared to the control group. The differences between the groups were examined by Hematoxilen Eosin staining with light microscopy and evaluated in terms of inflammatory cell infiltration, fibroblastic activity, collagen accumulation and neo-angiogenesis using the Ehrlich Hunt scale. After the experiments, all groups were stained with immunocytochemistry via TGF-β, VEGF and TNF-α antibodies. The statistical analysis was performed using the One-Way ANOVA test. When all these parameters were compared with the control group, a statistically significant difference was found.
Indexed as
Identifiers
39812920What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.